Brachytherapy Seeds Market Size, Share, Growth, and Industry Analysis by Type (High-dose rate (HDR) Brachytherapy, Low-dose rate (LDR) Brachytherapy), by Application (Prostate Cancer, Gynecological Cancer, Breast Cancer, Others), and Regional Forecast to 2033

Last Updated: 09 June 2025
SKU ID: 22367846

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

BRACHYTHERAPY SEEDS MARKET REPORT OVERVIEW

The global Brachytherapy Seeds Market size was valued at USD 0.36 billion in 2024 and is expected to reach USD 0.53 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.23% from 2025 to 2033.

Brachytherapy seeds are small radioactive sources that are directly implanted into a tumour or its surrounding tissues to deliver dedicated radiation therapy. Also referred as radiation seeds, these are used in the dealing of several tumours, comprising prostate, breast, gynaecological, head and neck, and lung cancers. The seeds are positioned into the body using dedicated devices or needles, directed by imaging methods such as ultrasound, CT scans, or MRI. Growing alertness of the benefits of brachytherapy, comprising its ability to provide targeted radiation with nominal damage to healthy surrounding tissues, is motivating augmented demand from both patients and healthcare supporters. Brachytherapy seeds present a minimally invasive treatment option that decreases the need for wide surgeries and leads to better-quality patient outcomes. The growing worldwide occurrence of cancer, specifically prostate cancer which is usually treated with brachytherapy works as a significant driver for the development of the brachytherapy seeds market.

Participants are fixing their efforts on encouraging R&D. Technological development are supporting the regional market growth. Companies need to stay updated with varying market trends and develop products that meet rising consumer needs. Companies coming up with advanced technological solutions for firming their positions. Government bodies and healthcare establishments are spending in cancer cure infrastructure and awareness plans, which benefit to promote the implementation of brachytherapy.

COVID-19 IMPACT

Pandemic Hampered The Market Due To Unexpected Disruption In The Sector

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic had a main impact on the brachytherapy seeds market, mainly due to instabilities in healthcare services and the interruption of non-urgent treatments. During the primary phases of the pandemic, numerous elective processes, comprising cancer treatments such as brachytherapy, were postponed or cancelled to line up COVID-19 patients and decline hospital experience. This led to a temporary let-down in demand for brachytherapy seeds.

LATEST TRENDS

Use Of Innovative Products To Boost The Market Growth

Technological upgrading and improvement will further enhance the presentation of the product, allowing it to obtain a varied range of requests in the market. Technological advancement will improve performance and propel the market growth. Technological development with high demand are increasingly setting a force to increase the productivity. Some players focus on product improvement to meet consumer requirements and likings. Continuous improvement in manufacturing of products is anticipated to stimulate product demand. Associations between brachytherapy seed producers, radiation oncologists, and research establishments are nurturing improvement, knowledge exchange, and the development of novel therapies, pushing the limitations of the market. Research into combination therapies is constant, and the successful integration of brachytherapy with other modalities could lead to more extensive implementation.

Global Brachytherapy Seeds Market Share, By Type, 2033

ask for customizationRequest a Free sample to learn more about this report

BRACHYTHERAPY SEEDS MARKET SEGMENTATION

By Type

According to type, the market can be segmented into High-dose rate (HDR) Brachytherapy, Low-dose rate (LDR) Brachytherapy

  • High-dose rate (HDR) Brachytherapy: High-dose rate (HDR) brachytherapy encompasses the provisional placement of radioactive sources near or inside the tumour. HDR brachytherapy offers a higher dose of radiation in a smaller period related to LDR brachytherapy, often necessitating multiple sessions.

 

  • Low-dose rate (LDR) Brachytherapy: Low-dose rate (LDR) brachytherapy encompasses the assignment of radioactive seeds that supply unremitting radiation over a protracted period, normally weeks to months. This type of brachytherapy is usually used for prostate cancer, even though it can also be used for gynaecological and breast cancers in certain cases.

By Application

According to application, the market can be segmented into Prostate Cancer, Gynecological Cancer, Breast Cancer, Others

  • Prostate Cancer: Prostate cancer is the most prevalent cancer type cured with brachytherapy, mainly LDR brachytherapy. The worldwide occurrence of prostate cancer is growing, which is anticipated to motivate the demand for brachytherapy seeds.

 

  • Gynecological Cancer: The use of brachytherapy for gynaecological cancers has been confirmed effective, with the capacity to exactly target tumours while reducing radiation exposure to nearby organs, such as the bladder and rectum.

 

  • Breast Cancer: HDR brachytherapy is progressively being used for patients with early-stage breast cancer, posing a targeted radiation dose to the tumour site while evading contact to healthy breast tissue.

 

  • Others: Other cancers such as head and neck cancer and skin cancer can also be cured with brachytherapy, mainly for localized tumours.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Rising Demand for Minimally Invasive Treatments To Boost The Market Growth

There is a rising fondness among patients and healthcare workers for minimally invasive procedures, which deal numerous benefits over traditional surgery, comprising shorter recovery times, less difficulties, and reduced hospital stays. Brachytherapy, being a minimally invasive procedure, is compatible to meet this demand. Patients desire outpatient dealings that allow them to return home on the same day, and brachytherapy's ability to provide accurate radiation to tumours while sparing nearby healthy tissue makes it a pleasing choice.

Technological Advancement and Innovation To Upsurge The Market

Technological advancements and innovation activate unique revenue augmenting opportunity which will upsurge the brachytherapy seeds market growth. Growing investment in research and development activities and growing awareness about benefits are expected to deliver profitable opportunities for the market. Continuous developments in the design and improvement of brachytherapy seeds have led to enhanced treatment consequences. The use of more effective radiation sources, and the growth of new delivery systems have expressively boosted the precision of radiation delivery.

Restraining Factor

Regulatory and Approval Challenges To Hamper The Market Growth

The regulatory framework governing brachytherapy devices can differ expressively across regions, which can generate blockades to market entry. Diverse countries have diverse approval procedures and compliance necessities, which can delay the commercialization of new brachytherapy products. Governing challenges, such as clinical trial requirements and the necessity for constant safety monitoring can also upsurge the time and charges involved in getting new products to market.

Opportunity

Growing Demand for Sustainable Construction To Create Opportunity in the Market

With growing global awareness around ecological sustainability and carbon footprint decline, the construction industry is under stress to implement ecological materials and procedures. Precast concrete line up with these goals by diminishing material waste, allowing energy efficacy, and supportive recycling initiatives. Governments and international bodies are executing severer ecological guidelines, creating major prospects for precast concrete producers to deal green solutions.

Challenge

Lack of Skilled Professionals Could Be a Major Challenge

Brachytherapy needs highly skilled professionals to guarantee accurate seed placement and dosimeter planning. The complexity of the process means that a lack of trained and experienced radiation oncologists, medical physicists, and technicians can limit the extensive implementation of brachytherapy.

BRACHYTHERAPY SEEDS MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East and Africa.

  • North America

North America region has a recognized healthcare infrastructure, high cancer incidence, and well-developed medical technologies, contributing to a sturdy demand for progressive cures which is expected to surge the brachytherapy seeds market share. United States, holds the largest share of the brachytherapy seeds market.

  • Asia

The Asia-Pacific region is observing rapid progress in the brachytherapy seeds market. Countries such as China and India are improving their healthcare infrastructure, which makes progressive treatments more reachable to the general inhabitants.

  • Europe

Europe has a well-established brachytherapy market. The region benefits from sturdy healthcare systems, progressive radiation therapy technologies, and a growing number of cancer cases.

KEY INDUSTRY PLAYERS

Key Players Focus On Partnerships To Gain Competitive Advantage

The key players are dynamically contributing in strategic events that are aimed at maintaining strong market position and increasing market share by merger, partnerships and others. Key players are motivated to introduce new innovative products. They are spending severely on research and development in order to arise with more new technology so that they can maintain and improve their existing market. The market changes are dynamic such as market expansion, partnership and merger. The collective efforts of these major players expressively impact the competitive landscape and future path of the market.

List of Top Brachytherapy Seeds Companies

  • Elekta (Sweden)
  • Bard Medical (India)
  • Varian Medical Systems (U.S.)
  • Eckert & Ziegler (Germany)

INDUSTRIAL DEVELOPMENT

March 2020: Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system took the silver award for radiation treatment advancements in the medical/dental category. 

REPORT COVERAGE

The report provides scrutiny and information according to market sectors. Business overview, financial overview, product portfolio, new project launch, recent development enquiry are the factors included in the profile. The report incorporates completely examined and appraised evidence of the noticeable players and their position in the market by methods for various descriptive tools. The report covers national and regional level market size and forecast. The report gives businesses the facility to research new prospect in many areas. The report shows to be an operational tool that players can use to gain a competitive superiority over their opponents and ensure lasting achievement in the market.

Brachytherapy Seeds Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 0.36 Billion in 2024

Market Size Value By

US$ 0.53 Billion by 2033

Growth Rate

CAGR of 4.23% from 2024 to 2033

Forecast Period

2025-2033

Base Year

2024

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • High-dose rate (HDR) Brachytherapy
  • Low-dose rate (LDR) Brachytherapy

By Application

  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Others

FAQs